3-Methyl-2-oxobutanoic acid (BioCAD00000003657)

blood cerebrospinal fluid (csf) feces saliva urine placenta

Metabolite Card

Formula: C5H8O3 (116.0473)
SMILES: CC(C)C(=O)C(O)=O

Synonyms [en]

3-Methyl-2-oxobutanoic acid; 3-methyl-2-oxobutanoate; 2-keto-3-methylbutyric acid; 2-ketovaline; 3-Methyl-2-oxobutyric acid; 3-methyl-2-oxo-butanoic acid

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

3-Methyl-2-oxobutanoic acid. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000003657). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

alpha-Ketoisovaleric acid is an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids. alpha-Ketoisovaleric acid is a neurotoxin, an acidogen, and a metabotoxin. A neurotoxin causes damage to nerve cells and nerve tissues. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of alpha-ketoisovaleric acid are associated with maple syrup urine disease. MSUD is a metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex (BCKDC), leading to a buildup of the branched-chain amino acids (leucine, isoleucine, and valine) and their toxic by-products (ketoacids) in the blood and urine. The symptoms of MSUD often show in infancy and lead to severe brain damage if untreated. MSUD may also present later depending on the severity of the disease. If left untreated in older individuals, during times of metabolic crisis, symptoms of the condition include uncharacteristically inappropriate, extreme, or erratic behaviour and moods, hallucinations, anorexia, weight loss, anemia, diarrhea, vomiting, dehydration, lethargy, oscillating hypertonia and hypotonia, ataxia, seizures, hypoglycemia, ketoacidosis, opisthotonus, pancreatitis, rapid neurological decline, and coma. In maple syrup urine disease, the brain concentration of branched-chain ketoacids can increase 10- to 20-fold. This leads to a depletion of glutamate and a consequent reduction in the concentration of brain glutamine, aspartate, alanine, and other amino acids. The result is a compromise of energy metabolism because of a failure of the malate-aspartate shuttle and a diminished rate of protein synthesis (PMID: 15930465). alpha-Ketoisovaleric acid is a keto-acid, which is a subclass of organic acids. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart, liver, and kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated MSUD. Many affected children with organic acidemias experience intellectual disability or delayed development.

Entity Information

DBLinks

Other DBLinks
  • CAS Registry Number: 759-05-7
  • PubChem: 3441
  • PubChem: 49
  • ChEBI: ChEBI:11851
  • ChEBI: ChEBI:16530
  • HMDB: HMDB0000019
  • HMDB: HMDB00019
  • HMDB: HMDB04260
  • LipidMaps: LMFA01020274
  • KEGG: C00141
  • BioCyc: 2-KETO-ISOVALERATE
  • NCBI MeSH: alpha-ketoisovalerate
  • Wikipedia: Alpha-Ketoisovaleric acid
  • Wikipedia: Alpha-Ketoisovaleric_acid
  • DrugBank: DB04074
  • RefMet: RM0153610
  • MoNA: EMBL_MCF_2_0_HRMS_Library000283
  • MoNA: GLS00033
  • MoNA: GLS00034
  • MoNA: HMDB0000019_c_ms_938
  • MoNA: HMDB0000019_c_ms_966
  • MoNA: HMDB0000019_ms_ms_31
  • MoNA: HMDB0000019_ms_ms_32
  • MoNA: KO001315
  • MoNA: KO001316
  • MoNA: KO001317
  • MoNA: KO001318
  • MoNA: MoNA032792
  • MoNA: MoNA032794
  • MoNA: MoNA032798
  • MoNA: MT000053
  • MoNA: OUF00289
  • MoNA: OUF00290
  • MoNA: PS068607
  • Metlin: METLIN_120
  • Coconut NaturalProduct: CNP0207859.0

Class / Ontology

Metabolic Network
ID EC Number Name
KEGG:R01209 4.2.1.9 2,3-dihydroxy-3-methylbutanoate hydro-lyase
KEGG:R01210 1.2.1.25 3-methyl-2-oxobutanoate:NAD+ oxidoreductase (CoA-mehtylpropanoylating)
KEGG:R01211 1.1.1.84 (R)-3,3-dimethylmalate:NAD+ oxidoreductase (decarboxylating)
KEGG:R01212 1.4.1.8 L-valine:NADP+ oxidoreductase (deaminating)
KEGG:R01213 2.3.3.13 acetyl-CoA:3-methyl-2-oxobutanoate C-acetyltransferase (thioester-hydrolysing, carboxymethyl-forming);
KEGG:R01214 2.6.1.6 L-valine:2-oxoglutarate aminotransferase
KEGG:R01215 2.6.1.66 L-valine:pyruvate aminotransferase
KEGG:R01216 2.1.2.11 2-dehydropantoate formaldehyde-lyase (3-methyl-2-oxobutanoate-forming)
KEGG:R01226 2.1.2.11 5,10-methylenetetrahydrofolate:3-methyl-2-oxobutanoate hydroxymethyltransferase
KEGG:R01434 1.4.1.9 L-valine:NAD+ oxidoreductase(deaminating)
KEGG:R01701 1.2.4.4 3-methyl-2-oxobutanoate:[dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] lipoyllysine 2-oxidoreductase (decarboxylating, acceptor-2-methylpropanoylating)
KEGG:R02200 2.6.1.32 valine:(S)-3-methyl-2-oxopentanoate aminotransferase
KEGG:R04441 4.2.1.9 (R)-2,3-dihydroxy-3-methylbutanoate hydro-lyase
KEGG:R07160 1.2.7.7 3-methyl-2-oxobutanoate:ferredoxin oxidoreductase (decarboxylating;CoA-2-methylpropanoylating)
KEGG:R07599 1.2.4.4 C00141 + C00068<=>C15976 + C00011
BioCyc:2-ISOPROPYLMALATESYN-RXN 2.3.3.13 2-KETO-ISOVALERATE + ACETYL-COA + WATER --> PROTON + 3-CARBOXY-3-HYDROXY-ISOCAPROATE + CO-A
BioCyc:3-CH3-2-OXOBUTANOATE-OH-CH3-XFER-RXN 2.1.2.11 METHYLENE-THF-GLU-N + 2-KETO-ISOVALERATE + WATER --> 2-DEHYDROPANTOATE + THF-GLU-N
BioCyc:DIHYDROXYISOVALDEHYDRAT-RXN 4.2.1.9 CPD-13357 --> 2-KETO-ISOVALERATE + WATER
BioCyc:BRANCHED-CHAINAMINOTRANSFERVAL-RXN 2.6.1.42 VAL + 2-KETOGLUTARATE<=>GLT + 2-KETO-ISOVALERATE
BioCyc:VALINE-PYRUVATE-AMINOTRANSFER-RXN 2.6.1.66 PYRUVATE + VAL<=>L-ALPHA-ALANINE + 2-KETO-ISOVALERATE
View More
Organism Source

Taxonomy Source

  1. Aloe africana [ncbi taxid: 1080010]
  2. Aloe ferox [ncbi taxid: 117798]
  3. Aloe spicata [ncbi taxid: 992642]
  4. Aloe vera [ncbi taxid: 34199]
  5. Arabidopsis thaliana [ncbi taxid: 3702]
  6. Citrullus lanatus [ncbi taxid: 3654]
  7. Escherichia coli K12 [ncbi taxid: ]
  8. Homo sapiens [ncbi taxid: 9606]
  9. Pyricularia oryzae [ncbi taxid: 318829]
  10. Saccharomyces cerevisiae [ncbi taxid: 4932]

Pathway Synthetic

pathway id name
BioCyc:CALBI_PWY3B3-1588 pantothenate and coenzyme A biosynthesis
BioCyc:CALBI_PWY-5057 valine degradation
BioCyc:CALBI_LEUSYN-PWY leucine biosynthesis
BioCyc:CALBI_PWY-5046 branched-chain α-keto acid dehydrogenase complexes
BioCyc:CALBI_BRANCHED-CHAIN-AA-SYN-PWY superpathway of leucine, valine, and isoleucine biosynthesis
BioCyc:CALBI_VALSYN-PWY valine biosynthesis
PathBank:SMP0000810 L-Alanine Metabolism
PathBank:SMP0000848 Pantothenate and CoA Biosynthesis
Plant Reactome:R-OAU-2744345 Metabolism and regulation
Plant Reactome:R-OAU-2744343 Amino acid metabolism
Plant Reactome:R-CME-1119540 Leucine biosynthesis
Plant Reactome:R-TAE-1119600 Valine biosynthesis
Plant Reactome:R-TAE-1119479 Valine degradation
Plant Reactome:R-TAE-1119496 Pantothenate biosynthesis I
Plant Reactome:R-FVE-5655122 Amino acid biosynthesis
Plant Reactome:R-MES-2744345 Metabolism and regulation
Plant Reactome:R-MES-2744343 Amino acid metabolism
Plant Reactome:R-MES-5655124 Amino acid catabolism
Plant Reactome:R-MES-2867929 Cofactor biosyntheses
Plant Reactome:R-TDI-2744345 Metabolism and regulation
View All Pathways